The approval of the Oxford and AstraZeneca vaccine for use in Britain offers a way out of the pandemic until the spring, when millions of vulnerable people have already been vaccinated, said UK Health Secretary Matt Hancock.
He said the recommended 12-week interval between the first and second doses of the AstraZeneca vaccine was “very helpful”, as more people would be able to take the first dose, which alone offers a large percentage. protection.
According to the British Minister of Health, hundreds of thousands of doses of the Oxford – AstraZeneca vaccine are ready to be released in Britain from Monday.
“The number of installments to be prepared next week is in the hundreds of thousands and then the numbers will increase,” he told the BBC.
However, he announced in advance that the restrictive measures will be extended to England, noting that he will refer to relevant details in the coming hours.
Johnson: Fantastic news
A triumph for British science was described by the Prime Minister of the United Kingdom, Boris Johnson, the approval received by the vaccine of the University of Oxford and AstraZeneca against the coronavirus.
“It’s really fantastic news – and a triumph for British science,” Johnson said on Twitter. “We will now vaccinate as many people as possible, as soon as possible,” he added.
The urgent approval of the Oxford and AstraZeneca vaccine comes at a time when, according to local authorities, Britain is experiencing “unprecedented” levels of infection, following the onset of the previous days of the coronavirus mutation, which is more easily transmitted without however, to cause – based on the evidence so far – a more serious disease Covid-19.
The United Kingdom is the first country to approve the vaccine and has ordered 100 million doses from AstraZeneca – enough to vaccinate 50 million people.
This is the second vaccine approved in the United Kingdom, after Pfizer and BioNTech. More than 600,000 people in the UK have been vaccinated since 90-year-old Margaret Keenan became the first person to get the Pfizer / BioNTech vaccine out of trial.
According to Reuters, BBC